**Table 1.** Relevant information about each individual.


|**Recod #**|**Gender**|**Age**|**Treatmet**|**Cholesterol**|**Systolic BP**|**Diastolic BP**|**Clasification**|**AHA**|
| ------- | :---: |:---:| :---: | :---: | :---: | :---: | :---: | :---: |
|SUJETO1_PPG|	F	| 61|	yes|	|283|	127	|84|	Prehypertensive|	E|
|SUJETO2_PPG|	M	| 64|	No|	162|	128	|84|	Prehypertensive|	E|
|SUJETO3_PPG|	F	| 44|	Yes|	170|124	|81	|Prehypertensive|	E|
|SUJETO4_PPG|	M	| 38|	No	|205|	126|	82	|Prehypertensive|	E|
|SUJETO5_PPG|	M	| 46|	Yes	|228|	220|	140	|Hypertensive Stage 2|	H|
|SUJETO6_PPG|	M	| 32|	Yes	|300|	122	|80	|Prehypertensive	|E|
|SUJETO7_PPG|	F	| 46|	No	|221|	123	|81	|Prehypertensive	|E|
|SUJETO8_PPG|	M	| 49|	No	|300|	125|	82	|Prehypertensive	|E|
|SUJETO9_PPG|	F	| 50|	No	|208|	130|	85	|Prehypertensive	|E|
|SUJETO10_PPG| M |32|	Yes	|234|	152	|98	|Hypertensive Stage 1	|H|
|SUJETO11_PPG| F |36|	No	|206|	164	|105	|Hypertensive Stage 2|	H|
|SUJETO12_PPG| M |56|	Yes	|143|	133	|86	|Prehypertensive	|E|
|SUJETO13_PPG| F |52|	Yes	|221|	133	|87	|Prehypertensive	|E|
|SUJETO14_PPG| F |49|	Yes	|229|	121	|81	|Prehypertensive	|E|
|SUJETO15_PPG| F |65|	Yes	|195|	138	|90	|Prehypertensive	|E|
|SUJETO16_PPG| M |47|	Yes	|223|	126	|83	|Prehypertensive	|E|
|SUJETO17_PPG| F |63|	Yes	|255|	139	|91	|Prehypertensive	|E|
|SUJETO18_PPG| F |48|	No	|239|	124	|81	|Prehypertensive	|E|
|SUJETO19_PPG| F |59|	No	|227|	124	|81	|Prehypertensive	|E|
|SUJETO20_PPG| F |80|	No	|230|	137	|89	|Prehypertensive	|E|
|SUJETO21_PPG| F |73|	No	|251|	153	|99	|Hypertensive Stage 1	|H|
|SUJETO22_PPG| F |71|	No	|138|	148	|96	|Hypertensive Stage 1|	H|
|SUJETO23_PPG| F |65|	No	|136|	141	|92	|Hypertensive Stage 1	|H|
|SUJETO24_PPG| F |62|	No	|194|	130	|85	|Prehypertensive	|E|
|SUJETO25_PPG| F |67|	No	|189|	136	|88	|Prehypertensive	|E|
|SUJETO26_PPG| F |64|	No	|170|	142	|92|	Hypertensive Stage 1|	H|
|SUJETO27_PPG| F |69|	No	|162	|133|	87|	Prehypertensive	|E|
|SUJETO28_PPG| F |61|	No	|149	|129|	85|	Prehypertensive	|E|
|SUJETO29_PPG| F |55|	No	|147	|148|	96|	Hypertensive Stage 1	|H|
|SUJETO30_PPG| F |73|	No	|144	|133|	87|	Prehypertensive	|E|
|SUJETO31_PPG|	M	|48|	Yes	|333	|159|	102|	Hypertensive Stage 1	|H|
|SUJETO32_PPG|	F	|59|	No	|135	|133|	86	|Prehypertensive	|E|
|SUJETO33_PPG|	M	|53|	No	|138	|139|	90	|Prehypertensive	|E|
|SUJETO34_PPG|	F	|55|	No	|234	|129|	85	|Prehypertensive	|E|
|SUJETO35_PPG|	F	|74|	No	|215	|129|	84	|Prehypertensive	|E|
|SUJETO36_PPG|	F	|78|	No	|201	|141|	92	|Hypertensive Stage 1|	H|
|SUJETO37_PPG|	F	|45|	No	|300	|152|	99	|Hypertensive Stage 1	|H|
|SUJETO38_PPG|	F	|77|	No	|226	|135|	88	|Prehypertensive	|E|
|SUJETO39_PPG|	M	|49|	No	|209	|127|	83	|Prehypertensive	|E|
|SUJETO40_PPG|	M	|52|	No	|213	|137|	89	|Prehypertensive	|E|
|SUJETO41_PPG|	M	|80|	No	|314	|129|	86	|Prehypertensive	|E|
|SUJETO42_PPG|	F	|71|	No	|276	|131|	85	|Prehypertensive	|E|
|SUJETO43_PPG|	F	|54|	No	|263	|127|	83	|Prehypertensive	|E|
|SUJETO44_PPG|	F	|33|	No	|137	|137|	89	|Prehypertensive	|E|
|SUJETO45_PPG| F |56|	Yes	|255	|140|	90	|Prehypertensive	|E|
|SUJETO46_PPG|	M	|58|	Yes	|247	|128|	84	|Prehypertensive	|E|
|Average| 	|	56.93|						
![image](https://github.com/user-attachments/assets/4ed5a26b-76d0-40ce-93af-a777d4500e8a)

